January Therapeutics is a biotechnology company focused on developing targeted therapies for chronic diseases using advanced drug delivery systems. Their approach aims to improve patient outcomes by enhancing the efficacy and safety of treatments while minimizing side effects.
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Developing targeted therapies for chronic diseases is challenging due to the difficulty of delivering drugs effectively to the affected tissues while minimizing systemic side effects. Traditional drug delivery methods often result in poor bioavailability and off-target drug distribution, limiting therapeutic efficacy.
Solution
January Therapeutics is a biotechnology company focused on improving patient outcomes by developing targeted therapies for chronic diseases using advanced drug delivery systems. Their approach aims to enhance the efficacy and safety of treatments by ensuring that therapeutic agents are precisely delivered to the site of action. This targeted delivery minimizes off-target effects, reducing the potential for adverse reactions and improving the overall therapeutic index of the drug.
Target Audience
The primary target audience includes patients with chronic diseases, as well as healthcare providers and pharmaceutical companies seeking more effective and safer treatment options.
Features
- Advanced drug delivery systems for targeted therapy
- Enhanced efficacy and safety profiles for chronic disease treatments
- Minimized systemic side effects through precise drug delivery